未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese Cases
Yamazaki, Emi; Fujimura, Taku; Takahashi-Watanabe, Manami; Amagai, Ryo; Tamabuchi, Erika; Oka, Kenta; Kambayashi, Yumi; Hashimoto, Akira; Omori, Ryoko; Takahashi, Takehiro; Asano, Yoshihide
分享
收藏The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study
Okuda-Hiwatashi, Saki; Amagai, Ryo; Fujimura, Taku; Kambayashi, Yumi; Watanabe-Takahashi, Manami; Yamazaki, Emi; Tamabuchi, Erika; Itabashi, Chisato; Hashimoto, Akira; Asano, Yoshihide
分享
收藏Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial
Yamazaki, Emi; Fujimura, Taku; Takahashi-Watanabe, Manami; Tada, Satsuki; Kitayama, Chisako; Amagai, Ryo; Kambayashi, Yumi; Watanabe, Masahiro; Maekawa, Masamitsu; Mano, Nariyasu; Asano, Yoshihide
分享
收藏A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial
Fujimura, Taku; Yoshino, Koji; Kato, Hiroshi; Fukushima, Satoshi; Ishizuki, Shoichiro; Otsuka, Atsushi; Matsushita, Shigeto; Amagai, Ryo; Muto, Yusuke; Yamazaki, Emi; Kambayashi, Yumi; Yahata, Takashi; Miyata, Toshio; Fujisawa, Yasuhiro; Asano, Yoshihide
分享
收藏
分享
收藏Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol
Fujimura, Taku; Yoshino, Koji; Nakamura, Motoki; Kato, Hiroshi; Ito, Takamichi; Maekawa, Takeo; Fujisawa, Yasuhiro; Matsushita, Shigeto; Amagai, Ryo; Yamazaki, Emi; Takahashi, Manami; Tamabuchi, Erika; Hashimoto, Akira; Kambayashi, Yumi; Yamazaki, Naoya; Miyata, Toshio; Asano, Yoshihide
分享
收藏Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results
Muto, Yusuke; Kambayashi, Yumi; Kato, Hiroshi; Fukushima, Satoshi; Ito, Takamichi; Maekawa, Takeo; Shoichiro, Ishizuki; Uchi, Hiroshi; Matsushita, Shigeto; Yamamoto, Yuki; Yoshino, Koji; Fujisawa, Yasuhiro; Amagai, Ryo; Ohuchi, Kentaro; Hashimoto, Akira; Asano, Yoshihide; Fujimura, Taku
分享
收藏Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas
Ohuchi, Kentaro; Amagai, Ryo; Ikawa, Tetsuya; Muto, Yusuke; Roh, Yuna; Endo, Junko; Maekawa, Takeo; Kambayashi, Yumi; Asano, Yoshihide; Fujimura, Taku
分享
收藏
分享
收藏
分享
收藏Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases
Muto, Yusuke; Kambayashi, Yumi; Kato, Hiroshi; Fukushima, Satoshi; Ito, Takamichi; Maekawa, Takeo; Fujisawa, Yasuhiro; Yoshino, Koji; Uchi, Hiroshi; Matsushita, Shigeto; Yamamoto, Yuki; Amagai, Ryo; Ohuchi, Kentaro; Hashimoto, Akira; Fujimura, Taku
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏